DEFIBROTIDE POUR LA PREVENTION ET LE TRAITEMENT DU SYNDROME DE LIBERATION DE CYTOKINES ET DE LA NEUROTOXICITE ASSOCIEE A L'IMMUNODEPLETION

• 收藏
• 分享

专利权人:

JAZZ PHARMACEUTICALS; INC.

发明人:

MCMAHON, SARAH,OKI, YASUHIRO

申请号：

CA3095335

公开号：

CA3095335A1

申请日:

2019.04.12

申请国别(地区):

CA

年份:

2019

代理人:

摘要：

The present disclosure provides method of preventing, lessening the effects, or treating cytokine release syndrome (CRS) or related disorders, and/or neurotoxicity associated with immunotherapy comprising administering defibrotide. The defibrotide can be administered after the immunotherapy begins or be administered prophylactically before immunotherapy begins or before the patient develops CRS and/or neurotoxicity.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/